Navigation Links
Scientists can predict nano drug outcome
Date:2/5/2009

Scientists including one from The University of Texas Health Science Center at Houston successfully predicted the outcome of a nano drug on breast tumors in a pre-clinical study. Their research could help determine which patients will respond best to cancer-fighting nano drugs.

Researchers from the Georgia Institute of Technology and Emory University also participated in the study, which appears in the February issue of Radiology.

The investigators used contrast agents encapsulated in tiny fat bubbles called liposomes to determine if breast tumors in rodents could be breached by liposomes loaded with a cancer drug called liposomal doxorubicin. The liposomes were administered intravenously.

When scientists X-rayed the rodents, the investigators received good images of porous breast tumors which had absorbed the contrast agents. On the other hand, poor images indicated the contrast agents had not substantially penetrated the tumor. When liposomal doxorubicin was administered, it was associated with better therapeutic results in the tumors with superior images.

"We can tell if the animals are candidates for the treatment or not," said Ananth Annapragada Ph.D., one of two senior authors and an associate professor at The University of Texas School of Health Information Sciences at Houston.

Higher uptake of the probe by the tumor, indicating leakier vasculature, was associated with a slower tumor growth rate, suggesting a better therapeutic outcome with liposomal doxorubicin, the authors wrote. A nanometer is a billionth of a meter and a liposome is about 100 nanometers.

Nano drugs for cancer like liposomal doxorubicin are designed to increase the amount of drug reaching tumors. Currently, when an intravenous cancer drug is administered, very little reaches its intended target. The remaining drug circulates in the bloodstream and can cause side effects.

Liposomes carrying drugs infiltrate leaky
'/>"/>

Contact: Robert Cahill
Robert.Cahill@uth.tmc.edu
713-500-3042
University of Texas Health Science Center at Houston
Source:Eurekalert

Page: 1 2

Related biology news :

1. CSHL scientists discover how companion cells to sperm protect them from genetic damage
2. Weizmann Institute scientists show extra copies of a gene carry extra risk
3. Scientists discover how deadly fungus protects itself
4. Scientists discover hot spot for toxic HABS off Washington coastline
5. Scientists uncover new class of non-protein coding genes in mammals with key functions
6. Smithsonian scientists receive coveted BBVA Ecology and Conservation Award
7. CSHL scientists clarify editing error underlying genetic neurodegenerative disease
8. Weizmann Institute scientists discover how cancer cells survive a chemotherapy drug
9. Substantial work ahead for water issues, say scientists at ACS Final Report briefing
10. CSHL scientists find a new class of small RNAs and define its function
11. Scientists uncover new genetic variations linked to psoriasis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...s that a common oral bacterium may exacerbate auto...al, "Unique Lipids from a Common Human Bacterium R...hancing Autoimmunity," appears in the December 200... Multiple sclerosis (MS), a disease where the imm...cts nearly 1 in 700 people in the United States. ...
(Date:11/23/2009)... the highest resolution images of peptides attachi...nderstanding how biomolecules manipulate the growt...ent for kidney stones using biomolecules. , The ...ion of the journal Proceedings of the National Ac... with mineral surfaces by accelerating, switching ...
(Date:11/23/2009)...ire microbiologist Louis Tisa has received two gra...the actinorhizal plants, widespread woody plants w...ated soils. , The United States Department of A...ecular, cellular and biomedical sciences, $399,000... bacteria Frankia and Casuarina, an actinorhizal p...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3UNH prof. receives nearly $500,000 to research environmentally significant plants 2Pitt researchers harness carbon nanomaterials for drug delivery systems oxygen sensors 54668 1Pitt researchers harness carbon nanomaterials for drug delivery systems oxygen sensors 54668 2A New Marketplace for Doctors DoctorFinders com 3A Free Market Solutions for Health Care 54667 1A New Marketplace for Doctors DoctorFinders com 3A Free Market Solutions for Health Care 54667 2Employee Benefits Industry Organizes to Protect Flexible Spending Accounts From Elimination or Contribution Limits 54665 1Employee Benefits Industry Organizes to Protect Flexible Spending Accounts From Elimination or Contribution Limits 54665 2Employee Benefits Industry Organizes to Protect Flexible Spending Accounts From Elimination or Contribution Limits 54665 3
... new mechanistic description of how tumor cells mi...of tumor metastasis. This new understanding holds ...is therapies. , Scientists know that tumor cells ...derstand the details of how this deadly migration ... Cancer Cell, EPFL Professor Melody Swartz and pos...
...ered how female cells are able to choose randomly ...e is always lucky. , Human males have both a X and.... This means that in an early stage in the develop... silence one of those two X chromosomes. This proc...rocess are related to serious genetic diseases. ...
... survey sponsored by CancerCare, a national nonpro...y (76 percent) of women surveyed said they know at...ain unaware of the important recent progress made ...ent) women ages 50-65 have heard of new therapies ...ss and information that women can use toward bette...
Other Biology News:Migration alert -- How tumor cells home in on the lymphatic system 2Physicist cracks women's random but always lucky choice of X chromosome 2Women well informed about breast cancer, yet lacking knowledge about current treatments 2
(Date:11/24/2009)...RNewswire-FirstCall/--GenomicHealth,Inc.(Nasdaq: G...xecutiveChairman,willpresentatthe21stAnnualPiperJa...cember1,2009at10:00a.m.ET. ,, Toaccessthelivean...ttheInvestorRelationssectionofGenomicHealth,swebsi...ecttothewebsiteatleast15minutespriortothebeginning...
(Date:11/23/2009)...n a provocative new study, a University of Utah sc...s the major cause of global warming cannot be st...ociety builds the equivalent of one new nuclear po...here will be any substantial near-term departure f...de emission rates," says the new paper by Tim Garr...
(Date:11/23/2009)...swire-FirstCall/-YMBioSciencesInc.(NYSEAmex: YMI ;...identifiesandadvancesadiverseportfolioofpromisingc...todayreportedthatCytopia(ASX:CYT)hascommencedenrol...lly-administeredJAK1/JAK2inhibitor.Thetrialisbeing...altomergeCytopiaintoYMhasbeenpreviouslyannouncedan...
(Date:11/23/2009)...PRNewswire/--Frost&Sullivan,theGrowthPartnersh...ngleadershipandinnovationThursday,November19,2009a...eldinSanAntonio,Texas. ,, (Logo: http://www.new...ealthcareInnovationAwardsaregiventocompaniesthatha...gementofhealthcare.Suchcompanieshaveshownsuccessat...
Breaking Biology Technology:Genomic Health to Present at Piper Jaffray Health Care Conference 2Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3
...e per capita income, retain more college graduates...options, the state announced Thursday a commitment...laureate degree programs. , ,The announcement, mad...art of the state,s strategy to play catch up in te...ees. Seven programs have been selected to receive ...
...ogy business, especially manufacturers and printer...Applied Technology Centers now under construction ... and at Waukesha County Technical College . , ,Bo...ea employers, especially in the area of workforce ...has received approval to move ahead with the Cente...
...a Madison software developer, achieved its 68th co...e months of 2006, thanks largely to a 125 percent ...d message transfer management products. , ,Citing ...ide actual sales numbers for MOVEit, but said Stan...rcent in 2005. The company employs less than 25 pe...
Other Biology Technology:State commits $500,000 to boost bachelor's degrees 2Applied Technology Centers to aid printing and manufacturing 2Applied Technology Centers to aid printing and manufacturing 3
Murashige and Skoog basal salt solution with Gamborg's B5 vitamins, 10X concentrate from Research Organics, Inc.
...ing allows a high-throuput screening of a biologic...r artifitially induced changes in the expression l... studied, classified and compared to each other, c...tized scanning of the hybridized slides in Agilent...
Rabbit Anti-Esa1 Polyclonal Antibody, Unconjugated from Abcam
Goat Anti-Human RORgamma (S-14) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: